163 related articles for article (PubMed ID: 31666197)
21. Histopathological Analysis in Testicular Tumors: 10 Years of Experience.
Kılınç F; Tas Ayçiçek S; Esen HH
Int J Surg Pathol; 2024 Apr; 32(2):331-339. PubMed ID: 37292006
[No Abstract] [Full Text] [Related]
22. Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding?
Vogt AP; Chen Z; Osunkoya AO
Hum Pathol; 2010 Sep; 41(9):1339-44. PubMed ID: 20573373
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
[TBL] [Abstract][Full Text] [Related]
24. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
Cohn-Cedermark G; Stahl O; Tandstad T;
Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
[TBL] [Abstract][Full Text] [Related]
25. Intertubular growth in pure seminomas: associations with poor prognostic parameters.
Browne TJ; Richie JP; Gilligan TD; Rubin MA
Hum Pathol; 2005 Jun; 36(6):640-5. PubMed ID: 16021570
[TBL] [Abstract][Full Text] [Related]
26. Reprint of: Updates in 2022 on the staging of testicular germ cell tumors.
Canete Portillo S; Rais-Bahrami S; Magi-Galluzzi C
Hum Pathol; 2023 Mar; 133():153-161. PubMed ID: 36898947
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis.
Alvarado-Cabrero I; Hernández-Toriz N; Paner GP
Am J Surg Pathol; 2014 Jan; 38(1):111-8. PubMed ID: 24145647
[TBL] [Abstract][Full Text] [Related]
28. Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?
Favilla V; Russo GI; Spitaleri F; Urzì D; Garau M; Madonia M; Saita A; Pirozzi Farina F; La Vignera S; Condorelli R; Calogero AE; Cimino S; Morgia G
Int Urol Nephrol; 2014 Jun; 46(6):1131-5. PubMed ID: 24318367
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited.
Aparicio J
Clin Transl Oncol; 2018 Oct; 20(10):1358-1359. PubMed ID: 29744734
[No Abstract] [Full Text] [Related]
30. The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985-1996.
Steele GS; Richie JP; Stewart AK; Menck HR
Cancer; 1999 Nov; 86(10):2171-83. PubMed ID: 10570449
[TBL] [Abstract][Full Text] [Related]
31. Predicting metastasized seminoma using gene expression.
Ruf CG; Linbecker M; Port M; Riecke A; Schmelz HU; Wagner W; Meineke V; Abend M
BJU Int; 2012 Jul; 110(2 Pt 2):E14-20. PubMed ID: 22243760
[TBL] [Abstract][Full Text] [Related]
32. Updates in 2022 on the staging of testicular germ cell tumors.
Canete Portillo S; Rais-Bahrami S; Magi-Galluzzi C
Hum Pathol; 2022 Oct; 128():152-160. PubMed ID: 35926809
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
[TBL] [Abstract][Full Text] [Related]
34. Updates in Staging and Reporting of Testicular Cancer.
Magers MJ; Idrees MT
Surg Pathol Clin; 2018 Dec; 11(4):813-824. PubMed ID: 30447843
[TBL] [Abstract][Full Text] [Related]
35. Nonseminomatous germ cell tumor of the testicle: does extensive staging of the primary tumor predict the likelihood of metastatic disease?
Rodriguez PN; Hafez GR; Messing EM
J Urol; 1986 Sep; 136(3):604-8. PubMed ID: 3016346
[TBL] [Abstract][Full Text] [Related]
36. Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas.
Lobo J; Stoop H; Gillis AJM; Looijenga LHJ; Oosterhuis W
Am J Surg Pathol; 2019 Dec; 43(12):1711-1719. PubMed ID: 31490238
[TBL] [Abstract][Full Text] [Related]
37. Paratesticular seminoma: echographic features and histological diagnosis with review of the literature.
Palicelli A; Neri P; Marchioro G; De Angelis P; Bondonno G; Ramponi A
APMIS; 2018 Mar; 126(3):267-272. PubMed ID: 29411910
[TBL] [Abstract][Full Text] [Related]
38. [Reduced retroperitoneal lymphadenectomy for clinical stage I non seminomatous germ cell testicular cancer].
Valdevenito Sepúlveda JP; Merhe Nieva E; Valdevenito Sepúlveda R; Cuevas Toro M; Gómez Gallo A; Bermúdez Luna H; Contreras Meléndez L; Gallegos Méndez I; Gallardo Escobar J; Palma Ceppi C
Arch Esp Urol; 2007 Apr; 60(3):245-54. PubMed ID: 17601299
[TBL] [Abstract][Full Text] [Related]
39. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
J Pediatr Urol; 2017 Aug; 13(4):386.e1-386.e7. PubMed ID: 28153774
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance.
Chung P; Daugaard G; Tyldesley S; Atenafu EG; Panzarella T; Kollmannsberger C; Warde P
Cancer Med; 2015 Jan; 4(1):155-60. PubMed ID: 25236854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
